The human side of influenza

Journal of Leukocyte Biology

Volumn 92, Issue 1, 2012, Pages 83-96

  Oshansky, Christine M ^a   Thomas, Paul G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Human; Immune response; Influenza

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CATHELICIDIN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLLECTIN; DEFENSIN; INFLUENZA VACCINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTRUCTURAL PROTEIN 1; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; VAX 102;

CELLULAR IMMUNITY; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG SAFETY; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; VIRUS IMMUNITY;

HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE;

MURINAE; ORTHOMYXOVIRIDAE;

EID: 84863469690     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1011506     Document Type: Review

References (209)

1. U.S. Centers for Disease Control and Prevention (2009) 2008-09 Influenza Prevention and Control Recommendations: Recommendations of the Advisory Committee on Immunization Practices (ACIP). CDC, Atlanta, GA, USA.
2. Peltola, V., Ziegler, T., Ruuskanen, O. (2003) Influenza A and B virus infections in children. Clin. Infect. Dis. 36, 299-305.
3. Heikkinen, T., Silvennoinen, H., Peltola, V., Ziegler, T., Vainionpaa, R., Vuorinen, T., Kainulainen, L., Puhakka, T., Jartti, T., Toikka, P., Lehtinen, P., Routi, T., Juven, T. (2004) Burden of influenza in children in the community. J. Infect. Dis. 190, 1369-1373.
4. Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., Herrera, G., Erdman, D., Hall, C. B., Seither, R., Griffin, M. R. (2006) The underrecognized burden of influenza in young children. N. Engl. J. Med. 355, 31-40.
5. Neuzil, K. M., Mellen, B. G., Wright, P. F., Mitchel Jr., E. F., Griffin, M. R. (2000) The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med. 342, 225-231.
6. Louie, J.K., Gavali, S., Acosta, M., Samuel, M.C., Winter, K., Jean, C., Glaser, C.A., Matyas, B.T., Schechter, R. (2010) Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch. Pediatr. Adolesc. Med. 164, 1023-1031.
7. Schanzer, D., Vachon, J., Pelletier, L. (2011) Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics? Am. J. Epidemiol. 174, 109-117.
8. Longini Jr., I. M., Koopman, J. S., Monto, A. S., Fox, J. P. (1982) Estimating household and community transmission parameters for influenza. Am. J. Epidemiol. 115, 736-751.
9. Viboud, C., Boelle, P. Y., Cauchemez, S., Lavenu, A., Valleron, A. J., Flahault, A., Carrat, F. (2004) Risk factors of influenza transmission in households. Br. J. Gen. Pract. 54, 684-689.
10. Neuzil, K. M., Zhu, Y., Griffin, M. R., Edwards, K. M., Thompson, J. M., Tollefson, S. J., Wright, P. F. (2002) Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J. Infect. Dis. 185, 147-152.
11. Pullan, C. R., Hey, E. N. (1982) Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br. Med. J. (Clin. Res. Ed). 284, 1665-1669.
12. Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B. (2000) Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161, 1501-1507.
13. Sigurs, N., Gustafsson, P. M., Bjarnason, R., Lundberg, F., Schmidt, S., Sigurbergsson, F., Kjellman, B. (2005) Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171, 137-141.
14. Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Bridges, C. B., Cox, N. J., Fukuda, K. (2004) Influenza-associated hospitaliza-tions in the United States. JAMA 292, 1333-1340.
15. Monto, A. S. (2002) Epidemiology of viral respiratory infections. Am. J. Med. 112 (Suppl. 6A), 4S-12S.
16. U.S. Centers for Disease Control and Prevention (2010) Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR 59, 1057-1062.
17. Nair, H., Brooks, W. A., Katz, M., Roca, A., Berkley, J. A., Madhi, S. A., Simmerman, J. M., Gordon, A., Sato, M., Howie, S., Krishnan, A., Ope, M., Lindblade, K. A., Carosone-Link, P., Lucero, M., Ochieng, W., Ka-mimoto, L., Dueger, E., Bhat, N., Vong, S., Theodoratou, E., Chit-taganpitch, M., Chimah, O., Balmaseda, A., Buchy, P., Harris, E., Evans, V., Katayose, M., Gaur, B., O'Callaghan-Gordo, C., Goswami, D., Arvelo, W., Venter, M., Briese, T., Tokarz, R., Widdowson, M. A., Mounts, A. W., Breiman, R. F., Feikin, D. R., Klugman, K. P., Olsen, S. J., Gessner, B. D., Wright, P. F., Rudan, I., Broor, S., Simoes, E. A., Campbell, H. (2011) Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378, 1917-1930.
18. Molinari, N. A., Ortega-Sanchez, I. R., Messonnier, M. L., Thompson, W. W., Wortley, P. M., Weintraub, E., Bridges, C. B. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25, 5086-5096.
19. Fairbrother, G., Cassedy, A., Ortega-Sanchez, I. R., Szilagyi, P. G., Edwards, K. M., Molinari, N. A., Donauer, S., Henderson, D., Ambrose, S., Kent, D., Poehling, K., Weinberg, G. A., Griffin, M. R., Hall, C. B., Finelli, L., Bridges, C., Staat, M. A. (2010) High costs of influenza: direct medical costs of influenza disease in young children. Vaccine 28, 4913-4919.
20. U.S. Centers for Disease Control and Prevention (2011) Standardization of terminology of the pandemic A(H1N1) 2009 virus. Wkly. Epidemiol. Rec. 86, 480.
21. Chowell, G., Bertozzi, S. M., Colchero, M. A., Lopez-Gatell, H., Alpu-che-Aranda, C., Hernandez, M., Miller, M. A. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N. Engl. J. Med. 361, 674-679.
22. Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quinones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C. E., Corrales, A., Higuera, A., Mondragon, E., Cordova-Villalobos, J. A. (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 361, 680-689.
23. Libster, R., Bugna, J., Coviello, S., Hijano, D. R., Dunaiewsky, M., Rey-noso, N., Cavalieri, M. L., Guglielmo, M. C., Areso, M. S., Gilligan, T., Santucho, F., Cabral, G., Gregorio, G. L., Moreno, R., Lutz, M. I., Pani-gasi, A. L., Saligari, L., Caballero, M. T., Egues Almeida, R. M., Gutierrez Meyer, M. E., Neder, M. D., Davenport, M. C., Del Valle, M. P., Santidrian, V. S., Mosca, G., Garcia Dominguez, M., Alvarez, L., Landa, P., Pota, A., Bolonati, N., Dalamon, R., Sanchez Mercol, V. I., Espinoza, M., Peuchot, J. C., Karolinski, A., Bruno, M., Borsa, A., Ferrero, F., Bo-nina, A., Ramonet, M., Albano, L. C., Luedicke, N., Alterman, E., Savy, V., Baumeister, E., Chappell, J. D., Edwards, K. M., Melendi, G. A., Po-lack, F. P. (2010) Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N. Engl. J. Med. 362, 45-55.
24. Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., Brammer, T. L., Cox, N. J., Tumpey, T. M., Katz, J. M. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945-1952.
25. Van Kerkhove, M. D., Vandemaele, K. A., Shinde, V., Jaramillo-Gutier-rez, G., Koukounari, A., Donnelly, C. A., Carlino, L. O., Owen, R., Pat-erson, B., Pelletier, L., Vachon, J., Gonzalez, C., Hongjie, Y., Zijian, F., Chuang, S. K., Au, A., Buda, S., Krause, G., Haas, W., Bonmarin, I., Taniguichi, K., Nakajima, K., Shobayashi, T., Takayama, Y., Sunagawa, T., Heraud, J. M., Orelle, A., Palacios, E., van der Sande, M. A., Wield-ers, C. C., Hunt, D., Cutter, J., Lee, V. J., Thomas, J., Santa-Olalla, P., Sierra-Moros, M. J., Hanshaoworakul, W., Ungchusak, K., Pebody, R., Jain, S., Mounts, A. W. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 8, e1001053.
26. U.S. Centers for Disease Control and Prevention (2009) Novel influenza A (H1N1) virus infections in three pregnant women-United States, April-May 2009. MMWR 58, 497-500.
27. Louie, J. K., Acosta, M., Jamieson, D. J., Honein, M. A. (2010) Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Engl. J. Med. 362, 27-35.
28. Jamieson, D. J., Honein, M. A., Rasmussen, S. A., Williams, J. L., Swerd-low, D. L., Biggerstaff, M. S., Lindstrom, S., Louie, J. K., Christ, C. M., Bohm, S. R., Fonseca, V. P., Ritger, K. A., Kuhles, D. J., Eggers, P., Bruce, H., Davidson, H. A., Lutterloh, E., Harris, M. L., Burke, C., Co-coros, N., Finelli, L., MacFarlane, K. F., Shu, B., Olsen, S. J. (2009) H1N1 2009 influenza virus infection during pregnancy in the U.S.A. Lancet 374, 451-458.
29. Zarychanski, R., Stuart, T.L., Kumar, A., Doucette, S., Elliott, L., Kett-ner, J., Plummer, F. (2010) Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 182, 257-264.
30. McCullers, J. A. (2006) Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571-582.
31. Murray, R. J., Robinson, J. O., White, J. N., Hughes, F., Coombs, G. W., Pearson, J. C., Tan, H. L., Chidlow, G., Williams, S., Christiansen, K. J., Smith, D. W. (2010) Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylo-coccus aureus co-infection. PLoS One 5, e8705.
32. U.S. Centers for Disease Control and Prevention (2009) Bacterial coin-fections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR 58, 1071-1074.
33. Mauad, T., Hajjar, L. A., Callegari, G. D., da Silva, L. F., Schout, D., Galas, F. R., Alves, V. A., Malheiros, D. M., Auler Jr., J. O., Ferreira, A. F., Borsato, M. R., Bezerra, S. M., Gutierrez, P. S., Caldini, E. T., Pasqualucci, C. A., Dolhnikoff, M., Saldiva, P. H. (2010) Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 181, 72-79.
34. Kreijtz, J. H., de Mutsert, G., van Baalen, C. A., Fouchier, R. A., Oster-haus, A. D., Rimmelzwaan, G. F. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol. 82, 5161-5166.
35. U.S. Centers for Disease Control and Prevention (2011) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 60, 1128-1132.
36. Couch, R. B. (1975) Assessment of immunity to influenza using artifi-cal challenge of normal volunteers with influenza virus. Dev. Biol. Stand. 28, 295-306.
37. Clements, M. L., Betts, R. F., Tierney, E. L., Murphy, B. R. (1986) Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24, 157-160.
38. Keitel, W. A., Atmar, R. L., Cate, T. R., Petersen, N. J., Greenberg, S. B., Ruben, F., Couch, R. B. (2006) Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch. Intern. Med. 166, 1121-1127.
39. Couch, R. B., Winokur, P., Brady, R., Belshe, R., Chen, W. H., Cate, T. R., Sigurdardottir, B., Hoeper, A., Graham, I. L., Edelman, R., He, F., Nino, D., Capellan, J., Ruben, F. L. (2007) Safety and immunoge-nicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 25, 7656-7663.
40. Brokstad, K. A., Eriksson, J. C., Cox, R. J., Tynning, T., Olofsson, J., Jonsson, R., Davidsson, A. (2002) Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. J. Infect. Dis. 185, 878-884.
41. Cox, R. J., Brokstad, K. A., Zuckerman, M. A., Wood, J. M., Haaheim, L. R., Oxford, J. S. (1994) An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 12, 993-999.
42. El-Madhun, A. S., Cox, R. J., Soreide, A., Olofsson, J., Haaheim, L. R. (1998) Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J. Infect. Dis. 178, 933-939.
43. Sasaki, S., Jaimes, M. C., Holmes, T. H., Dekker, C. L., Mahmood, K., Kemble, G. W., Arvin, A. M., Greenberg, H. B. (2007) Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81, 215-228.
44. Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mah-mood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., Wolff, M. (2000) Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 181, 1133-1137.
45. Belshe, R. B., Edwards, K. M., Vesikari, T., Black, S. V., Walker, R. E., Hultquist, M., Kemble, G., Connor, E. M. (2007) Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356, 685-696.
46. Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G. M., Mc-Causland, M., Kanchan, V., Kokko, K. E., Li, S., Elbein, R., Mehta, A. K., Aderem, A., Subbarao, K., Ahmed, R., Pulendran, B. (2011) Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786-795.
47. Clements, M. L., Murphy, B. R. (1986) Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 23, 66-72.
48. Ruben, F. L. (2004) Inactivated influenza virus vaccines in children. Clin. Infect. Dis. 38, 678-688.
49. Piedra, P. A., Gaglani, M. J., Kozinetz, C. A., Herschler, G., Riggs, M., Griffith, M., Fewlass, C., Watts, M., Hessel, C., Cordova, J., Glezen, W. P. (2005) Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 23, 1540-1548.
50. Esposito, S., Marchisio, P., Cavagna, R., Gironi, S., Bosis, S., Lamber-tini, L., Droghetti, R., Principi, N. (2003) Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 21, 3162-3168.
51. Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., Tashiro, M. (2001) The Japanese experience with vaccinating schoolchildren against influenza. N. Engl. J. Med. 344, 889-896.
52. Osterholm, M. T., Kelley, N. S., Sommer, A., Belongia, E. A. (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 12, 36-44.
53. Simonsen, L., Taylor, R. J., Viboud, C., Miller, M. A., Jackson, L. A. (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 7, 658-666.
54. Fireman, B., Lee, J., Lewis, N., Bembom, O., van der Laan, M., Baxter, R. (2009) Influenza vaccination and mortality: differentiating vaccine effects from bias. Am. J. Epidemiol. 170, 650-656.
55. Baxter, R., Ray, G. T., Fireman, B. H. (2010) Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 28, 7267-7272.
56. U.S. Centers for Disease Control and Prevention (2011) FluVaxView: Influenza Vaccination Coverage. CDC, Atlanta, GA, USA.
57. Carrat, F., Flahault, A. (2007) Influenza vaccine: the challenge of anti-genic drift. Vaccine 25, 6852-6862.
58. O'Hagan, D.T., Tsai, T., Reed, S. (2011) Emulsion-based adjuvants for improved influenza vaccines. In Influenza Vaccines for the Future, 2nd edition (G. Del Giudice, R. Rappuoli, eds.), Springer Basel AG, Switzerland, 327-357.
59. Podda, A. (2001) The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 19, 2673-2680.
60. Clark, T. W., Pareek, M., Hoschler, K., Dillon, H., Nicholson, K. G., Groth, N., Stephenson, I. (2009) Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361, 2424-2435.
61. O'Hagan, D. T. (2007) MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Exp. Rev. Vaccines 6, 699-710.
62. Vesikari, T., Groth, N., Karvonen, A., Borkowski, A., Pellegrini, M. (2009) MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. Vaccine 27, 6291-6295.
63. Vesikari, T., Pellegrini, M., Karvonen, A., Groth, N., Borkowski, A., O'Hagan, D.T., Podda, A. (2009) Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pedi-atr. Infect. Dis. J. 28, 563-571.
64. Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., Schmitt, H.J., Baehner, F., Borkowski, A., Tsai, T.F., Clemens, R. (2011) Oil-in-water emulsion adjuvant with influenza vaccine in young children. N. Engl. J. Med. 365, 1406-1416.
65. Huleatt, J. W., Nakaar, V., Desai, P., Huang, Y., Hewitt, D., Jacobs, A., Tang, J., McDonald, W., Song, L., Evans, R. K., Umlauf, S., Tussey, L., Powell, T. J. (2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26, 201-214.
66. Schotsaert, M., De Filette, M., Fiers, W., Saelens, X. (2009) Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev. Vaccines 8, 499-508.
67. Turley, C. B., Rupp, R. E., Johnson, C., Taylor, D. N., Wolfson, J., Tussey, L., Kavita, U., Stanberry, L., Shaw, A. (2011) Safety and immu-nogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 29, 5145-5152.
68. Ekiert, D. C., Friesen, R. H., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J., Brandenburg, B., Vogels, R., Brakenhoff, J. P., Kompier, R., Koldijk, M. H., Cornelissen, L. A., Poon, L. L., Peiris, M., Koudstaal, W., Wilson, I. A., Goudsmit, J. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843-850.
69. Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., Silacci, C., Fernandez-Rodriguez, B. M., Agatic, G., Bianchi, S., Giacchetto-Sasselli, I., Calder, L., Sallusto, F., Collins, P., Haire, L. F., Temperton, N., Lange-dijk, J. P., Skehel, J. J., Lanzavecchia, A. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856.
70. Whittle, J. R., Zhang, R., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Dormitzer, P. R., Haynes, B. F., Walter, E. B., Moody, M. A., Kepler, T. B., Liao, H. X., Harrison, S. C. (2011) Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 108, 14216-14221.
71. Ekiert, D. C., Bhabha, G., Elsliger, M. A., Friesen, R. H., Jongeneelen, M., Throsby, M., Goudsmit, J., Wilson, I. A. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251.
72. Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L. M., Santelli, E., Stec, B., Cadwell, G., Ali, M., Wan, H., Murakami, A., Yammanuru, A., Han, T., Cox, N. J., Bankston, L. A., Donis, R. O., Liddington, R. C., Marasco, W. A. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273.
73. Krause, J. C., Tsibane, T., Tumpey, T. M., Huffman, C. J., Basler, C. F., Crowe Jr., J. E. (2011) A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85, 10905-10908.
74. Smorodintseff, A. A., Tushinsky, M. D., Drobyshevskaya, I., Korovin, A. A., Osetroff, A. I. (1937) Investigation of volunteers infected with the influenza virus. Am. J. Med. Sci. 194, 159-170.
75. Johnson Jr., P. R., Feldman, S., Thompson, J. M., Mahoney, J. D., Wright, P. F. (1985) Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J. Med. Virol. 17, 325-335.
76. Johnson, P. R., Feldman, S., Thompson, J. M., Mahoney, J. D., Wright, P. F. (1986) Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J. Infect. Dis. 154, 121-127.
77. Treanor, J. J., Roth, F. K., Betts, R. F. (1990) Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults. J. Clin. Microbiol. 28, 596-599.
78. Knight, V., Kasel, J. A., Alford, R. H., Loda, F., Morris, J. A., Davenport, F. M., Robinson, R. Q., Buescher, E. L. (1965) New research on influenza: studies with normal volunteers. Combined Clinical Staff Conference at the National Institutes of Health. Ann. Intern. Med. 62, 1307-1325.
79. Treanor, J., Wright, P. F. (2003) Immune correlates of protection against influenza in the human challenge model. Dev. Biol. (Basel) 115, 97-104.
80. Killingley, B., Enstone, J., Booy, R., Hayward, A., Oxford, J., Ferguson, N., Van-Tam, J. N. (2011) Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect. Dis. 11, 879-886.
81. Garcia-Garcia, L., Valdespino-Gomez, J. L., Lazcano-Ponce, E., Jimenez-Corona, A., Higuera-Iglesias, A., Cruz-Hervert, P., Cano-Arellano, B., Garcia-Anaya, A., Ferreira-Guerrero, E., Baez-Saldana, R., Ferreyra-Reyes, L., Ponce-de-Leon-Rosales, S., Alpuche-Aranda, C., Rodriguez-Lopez, M. H., Perez-Padilla, R., Hernandez-Avila, M. (2009) Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 339, b3928.
82. Johns, M. C., Eick, A. A., Blazes, D. L., Lee, S. E., Perdue, C. L., Lipnick, R., Vest, K. G., Russell, K. L., DeFraites, R. F., Sanchez, J. L. (2010) Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5, e10722.
83. Cowling, B. J., Ng, S., Ma, E. S., Cheng, C. K., Wai, W., Fang, V. J., Chan, K. H., Ip, D. K., Chiu, S. S., Peiris, J. S., Leung, G. M. (2010) Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin. Infect. Dis. 51, 1370-1379.
84. Epstein, S. L. (2006) Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 193, 49-53.
85. Sonoguchi, T., Naito, H., Hara, M., Takeuchi, Y., Fukumi, H. (1985) Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J. Infect. Dis. 151, 81-88.
86. Hammitt, L. L., Bartlett, J. P., Li, S., Rahkola, J., Lang, N., Janoff, E. N., Levin, M. J., Weinberg, A. (2009) Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine 27, 7359-7366.
87. Corti, D., Suguitan Jr., A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., Weiss, R. A., Sallusto, F., Subbarao, K., Lanzavecchia, A. (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120, 1663-1673.
88. Wrammert, J., Koutsonanos, D., Li, G. M., Edupuganti, S., Sui, J., Mor-rissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., Mehta, A., Razavi, B., Del Rio, C., Zheng, N. Y., Lee, J. H., Huang, M., Ali, Z., Kaur, K., Andrews, S., Amara, R. R., Wang, Y., Das, S. R., O'Donnell, C. D., Yewdell, J. W., Subbarao, K., Marasco, W. A., Mulligan, M. J., Compans, R., Ahmed, R., Wilson, P. C. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181-193.
89. Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., Stevens, J., Wilson, I. A., Aguilar, P. V., Altschuler, E. L., Basler, C. F., Crowe Jr., J. E. (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455, 532-536.
90. Krause, J. C., Tumpey, T. M., Huffman, C. J., McGraw, P. A., Pearce, M. B., Tsibane, T., Hai, R., Basler, C. F., Crowe Jr., J. E. (2010) Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J. Virol. 84, 3127-3130.
91. Lee, L. Y., Ha do, L. A., Simmons, C., de Jong, M. D., Chau, N. V., Schumacher, R., Peng, Y. C., McMichael, A. J., Farrar, J. J., Smith, G. L., Townsend, A. R., Askonas, B. A., Rowland-Jones, S., Dong, T. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118, 3478-3490.
92. Richards, K. A., Topham, D., Chaves, F. A., Sant, A. J. (2010) Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J. Immunol. 185, 4998-5002.
93. Cusick, M. F., Wang, S., Eckels, D. D. (2009) In vitro responses to avian influenza H5 by human CD4 T cells. J. Immunol. 183, 6432-6441.
94. Ge, X., Tan, V., Bollyky, P. L., Standifer, N. E., James, E. A., Kwok, W. W. (2010) Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J. Virol. 84, 3312-3319.
95. Hayden, F. G., Fritz, R., Lobo, M. C., Alvord, W., Strober, W., Straus, S. E. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649.
96. Peiris, J. S., Yu, W. C., Leung, C. W., Cheung, C. Y., Ng, W. F., Nich-olls, J. M., Ng, T. K., Chan, K. H., Lai, S. T., Lim, W. L., Yuen, K. Y., Guan, Y. (2004) Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619.
97. Jorens, P. G., Van Damme, J., De Backer, W., Bossaert, L., De Jongh, R. F., Herman, A. G., Rampart, M. (1992) Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 4, 592-597.
98. Sung, R. Y., Hui, S. H., Wong, C. K., Lam, C. W., Yin, J. (2001) A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur. J. Pediatr. 160, 117-122.
99. Laham, F. R., Israele, V., Casellas, J. M., Garcia, A. M., Lac Prugent, C. M., Hoffman, S. J., Hauer, D., Thumar, B., Name, M. I., Pascual, A., Taratutto, N., Ishida, M. T., Balduzzi, M., Maccarone, M., Jackli, S., Pas-sarino, R., Gaivironsky, R. A., Karron, R. A., Polack, N. R., Polack, F. P. (2004) Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J. Infect. Dis. 189, 2047-2056.
100. Welliver, T. P., Garofalo, R. P., Hosakote, Y., Hintz, K. H., Avendano, L., Sanchez, K., Velozo, L., Jafri, H., Chavez-Bueno, S., Ogra, P. L., McKinney, L., Reed, J. L., Welliver Sr., R. C. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195, 1126-1136.
101. Garofalo, R. P., Hintz, K. H., Hill, V., Patti, J., Ogra, P. L., Welliver Sr., R. C. (2005) A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J. Med. Virol. 75, 282-289.
102. De Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J., Chau, T. N., Hoang, D. M., Chau, N. V., Khanh, T. H., Dong, V. C., Qui, P. T., Cam, B. V., Ha do, Q., Guan, Y., Peiris, J. S., Chinh, N. T., Hien, T. T., Farrar, J. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207.
103. Everard, M. L., Swarbrick, A., Wrightham, M., McIntyre, J., Dunkley, C., James, P. D., Sewell, H. F., Milner, A. D. (1994) Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child 71, 428-432.
104. Smith, P. K., Wang, S. Z., Dowling, K. D., Forsyth, K. D. (2001) Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J. Paediatr. Child Health 37, 146-151.
105. Salentin, R., Gemsa, D., Sprenger, H., Kaufmann, A. (2003) Chemo-kine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection. J. Leukoc. Biol. 74, 252-259.
106. Beigel, J. H., Farrar, J., Han, A. M., Hayden, F. G., Hyer, R., de Jong, M. D., Lochindarat, S., Nguyen, T. K., Nguyen, T. H., Tran, T. H., Ni-coll, A., Touch, S., Yuen, K. Y. (2005) Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353, 1374-1385.
107. Monsalvo, A. C, Batalle, J. P., Lopez, M. F., Krause, J. C, Klemenc, J., Hernandez, J. Z., Maskin, B., Bugna, J., Rubinstein, C, Aguilar, L., Da-lurzo, L., Libster, R., Savy, V., Baumeister, E., Cabral, G., Font, J., So-lari, L., Weller, K. P., Johnson, J., Echavarria, M., Edwards, K M., Chappell, J. D., Crowe Jr., J. E., Williams, J. V., Melendi, G. A., Polack, F. P. (2011) Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17, 195-199.
108. Long, C. B., Ramos, I., Rastogi, D., Manwani, D., Janow, G., Del Rio, M., Mayers, M., Herold, B. C, Fernandez-Sesma, A, Madan, R P. (2012) Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J. Pediatr. 160, 74-81.
109. Lawson, T. M., Man, S., Williams, S., Boon, A. C, Zambon, M., Borysie-wicz, L. K. (2001) Influenza A antigen exposure selects dominant V/317+ TCR in human CD8+ cytotoxic T cell responses. Int. Immunol. 13, 1373-1381.
110. Wagar, L. E., Gentleman, B., Pircher, H., McElhaney, J. E., Watts, T. H. (2011) Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS One 6, e23698.
111. Boon, A. C, Fringuelli, E., Graus, Y. M., Fouchier, R A, Sintnicolaas, K., Iorio, A. M., Rimmelzwaan, G. F., Osterhaus, A. D. (2002) Influenza A virus specific T cell immunity in humans during aging. Virology 299, 100-108.
112. McElhaney, J. E. (2011) Influenza vaccine responses in older adults. Ageing Res. Rev. 10, 379-388.
113. Murasko, D. M., Bernstein, E. D., Gardner, E. M., Gross, P., Munk, G., Dran, S., Abrutyn, E. (2002) Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp. Gerontol. 37, 427-439.
114. Co, M. D., Orphin, L., Cruz, J., Pazoles, P., Rothman, A. L., Ennis, F. A, Terajima, M. (2008) Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine 26, 1990-1998.
115. McElhaney, J. E., Xie, D., Hager, W. D., Barry, M. B., Wang, Y., Klep-pinger, A, Ewen, C, Kane, K. P., Bleackley, R C. (2006) T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 176, 6333-6339.
116. La Ruche, G., Tarantola, A, Barboza, P., Vaillant, L., Gueguen, J., Gas-tellu-Etchegorry, M. (2009) The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill 14, pii: 19366.
117. Webb, S. A, Pettila, V., Seppelt, I., Bellomo, R., Bailey, M., Cooper, D. J., Cretikos, M., Davies, A. R, Finfer, S., Harrigan, P. W., Hart, G K, Howe, B., Iredell, J. R, McArthur, C, Mitchell, I., Morrison, S., Nichol, A. D., Paterson, D. L., Peake, S., Richards, B., Stephens, D., Turner, A, Yung, M. (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N. Engl. J. Med. 361, 1925-1934.
118. U.S. Centers for Disease Control and Prevention (1919) Public Health Weekly Reports for October 17, 1919. Public Health Rep. 34, 2289-2333.
119. Tang, Y W., Li, H., Wu, H., Shyr, Y, Edwards, K. M. (2007) Host sin-gle-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J. Infect. Dis. 196, 1021-1025.
120. Zuniga, J., Buendia, I., Zhao, Y, Jimenez, L., Torres, D., Romo, J., Ramirez, G., Cruz, A, VargasAlarcon, G., Sheu, C. C, Chen, F., Su, L., Tager, A M., Pardo, A, Selman, M., Christiani, D. C. (2011) Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur. Respir. J., Epub ahead of print. doi: 10.1183/09031936.00020611.
121. Gianfrani, C, Oseroff, C, Sidney, J., Chesnut, R W., Sette, A. (2000) Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 61, 438-452.
122. Wahl, A, Schafer, F., Bardet, W., Buchli, R, Air, G. M., Hildebrand, W. H. (2009) HLA class I molecules consistently present internal influenza epitopes. Proc. Natl. Acad. Sci. USA 106, 540-545.
123. Rouse, B. T., Sehrawat, S. (2010) Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10, 514-526.
124. Suzuki, T., Chow, C. W., Downey, G. P. (2008) Role of innate immune cells and their products in lung immunopathology. Int. J. Biochem. Cell Biol. 40, 1348-1361.
125. Subrata, L. S., Bizzintino, J., Mamessier, E., Bosco, A, McKenna, K. L., Wikstrom, M. E., Goldblatt, J., Sly, P. D., Hales, B. J., Thomas, W. R, Laing, I. A, LeSouef, P. N., Holt, P. G. (2009) Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J. Immunol. 183, 2793-2800.
126. Fernandez-Sesma, A, Marukian, S., Ebersole, B. J., Kaminski, D., Park, M. S., Yuen, T., Sealfon, S. C, Garcia-Sastre, A, Moran, T. M. (2006) Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295-6304.
127. Osterlund, P., Pirhonen, J., Ikonen, N., Ronkkö, E., Strengell, M., Makela, S. M., Broman, M, Hamming, O. J., Hartmann, R, Ziegler, T., Julkunen, I. (2010) Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J. Virol. 84, 1414-1422.
128. Guillot, L., Le Goffic, R, Bloch, S., Escriou, N., Akira, S., Chignard, M., Si-Tahar, M. (2005) Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280, 5571-5580.
129. Barchet, W., Krug, A, Cella, M., Newby, C, Fischer, J. A, Dzionek, A, Pekosz, A, Colonna, M. (2005) Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways. Eur. J. Immunol. 35, 236-242.
130. Lund, J. M., Alexopoulou, L., Sato, A, Karow, M., Adams, N. C, Gale, N. W., Iwasaki, A, Flavell, R A. (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101, 5598-5603.
131. Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., Schwemmle, M., Gunther, S., Drosten, C, Michiels, T., Staeheli, P. (2010) A Interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670-5677.
132. Hartshorn, K. L., Crouch, E. C, White, M. R, Eggleton, P., Tauber, A. I., Chang, D., Sastry, K. (1994) Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94, 311-319.
133. Hartshorn, K. L., White, M. R, Voelker, D. R, Coburn, J., Zaner, K., Crouch, E. C. (2000) Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem. J. 351, 449-458.
134. LeVine, A. M., Whitsett, J. A, Hartshorn, K. L., Crouch, E. C, Korfha-gen, T. R (2001) Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J. Immunol. 167, 5868-5873.
135. LeVine, A. M., Hartshorn, K, Elliott, J., Whitsett, J., Korfhagen, T. (2002) Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L563-L572.
136. Hartshorn, K. L., Collamer, M., Auerbach, M., Myers, J. B., Pavlotsky, N, Tauber, A. I. (1988) Effects of influenza A virus on human neutrophil calcium metabolism. J. Immunol. 141, 1295-1301.
137. Bals, R, Wang, X., Zasloff, M., Wilson, J. M. (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95, 9541-9546.
138. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R, Jornvall, H., Wigzell, H., Gudmundsson, G. H. (2000) The human antimicrobial and chemotactic peptides LL-37 and a-de-fensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
139. Barlow, P. G., Svoboda, P., Mackellar, A, Nash, A. A, York, I. A, Pohl, J., Davidson, D. J., Donis, R O. (2011) Antiviral activity and increased host defense against influenza infection elicited by the human catheli-cidin LL-37. PLoS One 6, e25333.
140. Lehrer, R I., Barton, A, Daher, K. A, Harwig, S. S., Ganz, T., Selsted, M. E. (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84, 553-561.
141. Ashitani, J., Mukae, H., Hiratsuka, T., Nakazato, M., Kumamoto, K, Matsukura, S. (2002) Elevated levels of a-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121, 519-526.
142. Territo, M. C, Ganz, T., Selsted, M. E., Lehrer, R (1989) Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84, 2017-2020.
143. Hartshorn, K. L., White, M. R, Shepherd, V., Reid, K, Jensenius, J. C, Crouch, E. C. (1997) Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 273, L1156-L1166.
144. Daher, K. A, Selsted, M. E., Lehrer, R I. (1986) Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60, 1068-1074.
145. Salvatore, M., Garcia-Sastre, A, Ruchala, P., Lehrer, R.I., Chang, T., Klotman, M. E. (2007) α-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J. Infect. Dis. 196, 835-843.
146. Geissmann, F., Jung, S., Littman, D. R (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
147. Belge, K. U., Dayyani, F., Horelt, A, Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., Ziegler-Heitbrock, L. (2002) The proinflammatory CD14 + CD16 + DR++ monocytes are a major source of TNF. J. Immunol. 168, 3536-3542.
148. Fingerle, G., Pforte, A, Passlick, B., Blumenstein, M., Strobel, M., Ziegler-Heitbrock, H. W. (1993) The novel subset of CD14 + /CD16 + blood monocytes is expanded in sepsis patients. Blood 82, 3170-3176.
149. Cros, J., Cagnard, N., Woollard, K, Patey, N., Zhang, S. Y, Senechal, B., Puel, A, Biswas, S. K, Moshous, D., Picard, C, Jais, J. P., D'Cruz, D., Casanova, J. L., Trouillet, C, Geissmann, F. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33, 375-386.
150. Azeredo, E. L., Neves-Souza, P. C, Alvarenga, A. R, Reis, S. R, Torren-tes-Carvalho, A, Zagne, S. M., Nogueira, R M., Oliveira-Pinto, L. M., Kubelka, C. F. (2010) Differential regulation of Toll-like receptor-2, Toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130, 202-216.
151. Grage-Griebenow, E., Zawatzky, R., Kahlert, H., Brade, L., Flad, H., Ernst, M. (2001) Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. Eur. J. Immunol. 31, 48-56.
152. Masten, B. J., Olson, G. K, Tarleton, C. A., Rund, C, Schuyler, M., Mehran, R, Archibeque, T., Lipscomb, M. F. (2006) Characterization of myeloid and plasmacytoid dendritic cells in human lung. J. Immunol. 177, 7784-7793.
153. Gill, M. A., Long, K, Kwon, T., Muniz, L., Mejias, A, Connolly, J., Roy, L., Banchereau, J., Ramilo, O. (2008) Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J. Infect. Dis. 198, 1667-1676.
154. Hale, B. G., Randall, R E., Ortin, J., Jackson, D. (2008) The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89, 2359-2376.
155. Garcia-Sastre, A, Egorov, A, Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P., Muster, T. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330.
156. Versteeg, G. A, Hale, B. G., van Boheemen, S., Wolff, T., Lenschow, D. J., Garcia-Sastre, A. (2010) Species-specific antagonism of host ISGy-lation by the influenza B virus NS1 protein. J. Virol. 84, 5423-5430.
157. Serbina, N. V., Jia, T., Hohl, T. M., Pamer, E. G. (2008) Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421-452.
158. Dawson, T. C, Beck, M. A, Kuziel, W. A, Henderson, F., Maeda, N. (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156, 1951-1959.
159. - mice. J. Leukoc. Biol. 81, 793-801.
160. Aldridge Jr., J. R, Moseley, C. E., Boltz, D. A., Negovetich, N. J., Reynolds, C, Franks, J., Brown, S. A, Doherty, P. C, Webster, R G., Thomas, P. G. (2009) TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. USA 106, 5306-5311.
161. Marcelin, G., Aldridge, J. R, Duan, S., Ghoneim, H. E., Rehg, J., Mar-juki, H., Boon, A. C, McCullers, J. A, Webby, R. J. (2011) Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden in pregnant mice. J. Virol. 85, 11208-11219.
162. Herold, S., von Wulffen, W, Steinmueller, M., Pleschka, S., Kuziel, W. A, Mack, M., Srivastava, M., Seeger, W., Maus, U. A, Lohmeyer, J. (2006) Alveolar epithelial cells direct monocyte transepithelial migra tion upon influenza virus infection: impact of chemokines and adhe sion molecules. J. Immunol. 177, 1817-1824.
163. Wareing, M. D., Shea, A. L., Inglis, C. A, Dias, P. B., Sarawar, S. R (2007) CXCR2 is required for neutrophil recruitment to the lung dur ing influenza virus infection, but is not essential for viral clearance. Viral Immunol. 20, 369-378.
164. Seo, S. U., Kwon, H. J., Ko, H. J., Byun, Y. H., Seong, B. L., Uematsu, S., Akira, S., Kweon, M. N. (2011) Type I interferon signaling regulates Ly6C monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog. 7, e1001304.
165. Monticelli, L. A, Sonnenberg, G. F., Abt, M. C, Alenghat, T., Ziegler, C. G., Doering, T. A, Angelosanto, J. M., Laidlaw, B. J., Yang, C. Y, Sathaliyawala, T., Kubota, M., Turner, D., Diamond, J. M., Goldrath, A. W., Farber, D. L., Collman, R G., Wherry, E. J., Artis, D. (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045-1054.
166. Colamussi, M. L., White, M. R, Crouch, E., Hartshorn, K L. (1999) Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 93, 2395-2403.
167. Fesq, H., Bacher, M., Nain, M., Gemsa, D. (1994) Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 190, 175-182.
168. Craft, A. W., Reid, M. M., Low, W. T. (1976) Effect of virus infections on polymorph function in children. Br. Med. J. 1, 1570.
169. Kleinerman, E. S., Snyderman, R, Daniels, C. A. (1975) Depressed monocyte chemotaxis during acute influenza infection. Lancet 2, 1063-1066.
170. Martin, R R, Couch, R B., Greenberg, S. B., Cate, T. R, Warr, G. A. (1981) Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. J. Infect. Dis. 144, 279-280.
171. Sato, M., Hosoya, M., Wright, P. F. (2009) Differences in serum cytokine levels between influenza virus A and B infections in children. Cytokine 47, 65-68.
172. Divanovic, S., Lai, A. C. (2004) Cytokine induction in human cord blood lymphocytes after pulsing with UV-inactivated influenza viruses. Immunol. Lett. 94, 201-207.
173. Rosenau, J. M. (1919) Experiments to determine mode of spread of influenza. JAMA 73, 311-313.
174. Liu, W., de Vlas, S. J., Tang, F., Ma, M. J., Wei, M. T., Liu, L. J., Li, Z. D., Zhang, L., Xin, Z. T., Tong, Y G., Jiang, T., Zhang, X. A, He, C, Li, C, Xu, X. N., Yang, H., Richardus, J. H., Cao, W. C. (2010) Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination. Clin. Infect. Dis. 51, 1028-1032.
175. Gerhard, W. (2001) The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 260, 171-190.
176. Khurana, S., Suguitan Jr., A. L., Rivera, Y, Simmons, C. P., Lanzavec-chia, A, Sallusto, F., Manischewitz, J., King, L. R, Subbarao, K, Gold-ing, H. (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 6, e1000049.
177. Greenbaum, J. A, Kotturi, M. F., Kim, Y, Oseroff, C, Vaughan, K, Sa-limi, N., Vita, R, Ponomarenko, J., Scheuermann, R H., Sette, A, Peters, B. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. USA 106, 20365-20370.
178. Collin, M., Bigley, V., Haniffa, M., Hambleton, S. (2011) Human dendritic cell deficiency: the missing ID? Nat. Rev. Immunol 11, 575-583.
179. Bhardwaj, N., Bender, A, Gonzalez, N., Bui, L. K, Garrett, M. C, Steinman, R M. (1994) Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94, 797-807.
180. Cella, M., Facchetti, F., Lanzavecchia, A, Colonna, M. (2000) Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1, 305-310.
181. Sareneva, T., Matikainen, S., Kurimoto, M., Julkunen, I. (1998) Influenza A virus-induced IFN-a//3 and IL-18 synergistically enhance IFN-7 gene expression in human T cells. J. Immunol. 160, 6032-6038.
182. De Bree, G. J., van Leeuwen, E. M., Out, T. A, Jansen, H. M., Jonkers, R E., van Lier, R A. (2005) Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J. Exp. Med. 202, 1433-1442.
183. Piet, B., de Bree, G. J., Smids-Dierdorp, B. S., van der Loos, C. M., Remmerswaal, E. B., von der Thusen, J. H., van Haarst, J. M., Eeren-berg, J. P., ten Brinke, A, van der Bij, W., Timens, W., van Lier, R A, Jonkers, R E. (2011) CD8 T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J. Clin. Invest. 121, 2254-2263.
184. Hillaire, M. L., van Trierum, S. E., Bodewes, R, van Baalen, C. A, van Binnendijk, R S., Koopmans, M. P., Fouchier, R A, Osterhaus, A. D., Rimmelzwaan, G. F. (2011) Characterization of the human CD8+ T cell response following infection with 2009 pandemic influenza H1N1 virus. J. Virol. 85, 12057-12061.
185. Baluch, A, Humar, A, Egli, A, Gubbay, J., Lisboa, L., Wilson, L., Kumar, D. (2011) Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS One 6, e28627.
186. Scheible, K, Zhang, G., Baer, J., Azadniv, M., Lambert, K, Pryhu-ber, G., Treanor, J. J., Topham, D.J. (2011) CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine 29, 2159-2168.
187. Tu, W., Mao, H., Zheng, J., Liu, Y, Chiu, S. S., Qin, G., Chan, P. L., Lam, K T., Guan, J., Zhang, L., Guan, Y, Yuen, K Y, Peiris, J. S., Lau, Y L. (2010) Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 84, 6527-6535.
188. Gras, S., Kedzierski, L., Valkenburg, S. A, Laurie, K, Liu, Y C, Denholm, J. T., Richards, M. J., Rimmelzwaan, G. F., Kelso, A., Doherty, P. C, Turner, S. J., Rossjohn, J., Kedzierska, K (2010) Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl. Acad. Sci. USA 107, 12599-12604.
189. Bonneville, M., O'Brien, R L., Born, W.K. (2010) 78 T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol 10, 467-478.
190. Qin, G., Mao, H., Zheng, J., Sia, S. F., Liu, Y, Chan, P. L., Lam, K T., Peiris, J. S., Lau, Y L., Tu, W. (2009) Phosphoantigen-expanded human 78 T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J. Infect. Dis. 200, 858-865.
191. Qin, G., Liu, Y, Zheng, J., Ng, I. H., Xiang, Z., Lam, K T., Mao, H., Li, H., Peiris, J. S., Lau, Y L., Tu, W. (2011) Type 1 responses of human V79VS2 T cells to influenza A viruses. J. Virol. 85, 10109-10116.
192. Culley, F. J., Pollott, J., Openshaw, P.J. (2002) Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196, 1381-1386.
193. Dakhama, A, Park, J. W., Taube, C, Joetham, A, Balhorn, A, Miya-hara, N., Takeda, K, Gelfand, E. W. (2005) The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J. Immunol. 175, 1876-1883.
194. You, D., Becnel, D., Wang, K., Ripple, M., Daly, M., Cormier, S. A. (2006) Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir. Res. 7, 107.
195. You, D., Ripple, M., Balakrishna, S., Troxclair, D., Sandquist, D., Ding, L., Ahlert, T. A., Cormier, S. A. (2008) Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J. Immunol. 181, 3486-3494.
196. Sihoe, A. D., Wong, R. H., Lee, A. T., Lau, L. S., Leung, N. Y, Law, K. I., Yim, A. P. (2004) Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest 125, 2345-2351.
197. Lee, N., Hui, D., Wu, A, Chan, P., Cameron, P., Joynt, G. M., Ahuja, A, Yung, M. Y, Leung, C. B., To, K. F., Lui, S. F., Szeto, C. C, Chung, S., Sung, J. J. (2003) A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986-1994.
198. Boon, A. C, de Mutsert, G., Graus, Y M., Fouchier, R. A, Sintnicolaas, K., Osterhaus, A. D., Rimmelzwaan, G. F. (2002) The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J. Virol. 76, 582-590.
199. Bednarek, M. A, Sauma, S. Y, Gammon, M. C, Porter, G., Tamhan-kar, S., Williamson, A. R., Zweerink, H. J. (1991) The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.J. Immunol. 147, 4047-4053.
200. Wu, C, Zanker, D., Valkenburg, S., Tan, B., Kedzierska, K, Zou, Q. M., Doherty, P. C, Chen, W. (2011) Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals. Proc. Natl. Acad. Sci. USA 108, 9178-9183.
201. Lehner, P. J., Wang, E. C, Moss, P. A, Williams, S., Platt, K, Friedman, S. M., Bell, J. I., Borysiewicz, L. K. (1995) Human HLAA0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 181, 79-91.
202. Boon, A. C., deBeauchamp, J., Hollmann, A., Luke, J., Kotb, M., Rowe, S., Finkelstein, D., Neale, G., Lu, L., Williams, R. W., Webby, R. J. (2009) Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J. Virol. 83, 10417-10426.
203. U.S. Centers for Disease Control and Prevention (2003) Diabetes prevalence among American Indians and Alaska Natives and the overall population-United States, 1994-2002. MMWR 52, 702-704.
204. Boon, A. C., De Mutsert, G., Fouchier, R. A., Sintnicolaas, K., Oster-haus, A. D., Rimmelzwaan, G. F. (2004) Preferential HLA usage in the influenza virus-specific CTL response. J. Immunol. 172, 4435-4443.
205. Nakaya, H. I., Li, S., Pulendran, B. (2011) Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Inter-discip. Rev. Syst. Biol. Med. 4, 193-205.
206. Anders, E. M., Hartley, C. A., Reading, P. C., Ezekowitz, R. A. (1994) Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J. Gen. Virol. 75, 615-622.
207. Kase, T., Suzuki, Y., Kawai, T., Sakamoto, T., Ohtani, K., Eda, S., Maeda, A., Okuno, Y., Kurimura, T., Wakamiya, N. (1999) Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97, 385-392.
208. Eisen, D. P. (2010) Mannose-binding lectin deficiency and respiratory tract infection. J. Innate Immun. 2, 114-122.
209. Eisen, D. P., Marshall, C., Dean, M. M., Sasadeusz, J., Richards, M., Buising, K., Cheng, A., Johnson, P. D., Barr, I. G., McBryde, E. S. (2011) No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus. Hum. Immunol. 72, 1091-1094.